Literature DB >> 28495190

Antibodies to Toxoplasma gondii and Leishmania spp. in domestic cats from Luanda, Angola.

Ana Patrícia Lopes1, Ana Cristina Oliveira2, Sara Granada2, Filipa T Rodrigues3, Elias Papadopoulos4, Henk Schallig5, Jitender P Dubey6, Luís Cardoso7.   

Abstract

Toxoplasma gondii and Leishmania spp. are zoonotic protozoa of importance to animal and public health. The present study aimed to assess for the first time the seroprevalence of these zoonotic parasites in a domestic feline population living in Luanda, Angola. One hundred and two cats were sampled at a veterinary medical centre, from May 2014 to February 2016. The age of the cats ranged from 2.5 to 143 months (median: 12 months; interquartile range: 7.5-24). Serum samples were tested for immunoglobulin (Ig) G antibodies to T. gondii at two-fold dilutions of 1:20 to 1:2560 with a modified agglutination test (MAT) commercial kit. The direct agglutination test (DAT) for titration of IgG antibodies specific to Leishmania spp. used a standard freeze-dried antigen at a concentration of 5×107 promastigotes per milliliter, following a predefined protocol. Two-fold dilution series ranging from 1:25 to 1:800 were tested, with a cut-off titre of 100 chosen for seropositivity. Four out of 102 cats (3.9%; 95% confidence interval [CI]: 1.1-9.7) had antibodies to T. gondii: one had a titer of 20, one a titer of 160, and two had a titer≥2560. No cat (0.0%; CI: 0.0-3.5) was found seropositive for Leishmania spp. A statistically significant difference was found between T. gondii seroprevalence and Leishmania spp. seroprevalence (p=0.043). The odds of a cat being seropositive to T. gondii increased by an average factor of 1.58 for each 1-year increase in age (p=0.003). The sampled cats were well-cared animals and may not represent the overall feline population of Angola at the national and city levels. The fact that only 12 out of the 102 sampled cats ate or had access to raw or undercooked meat and/or viscera may have reduced the likelihood of finding seropositive results. Under these circumstances, additional studies, including a larger number of cats, are necessary for a more comprehensive assessment of the zoonotic risk posed by these animals in Angola.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Angola; Antibodies; Cat feline; Leishmania; Luanda; Seroprevalence; Toxoplasma

Mesh:

Substances:

Year:  2017        PMID: 28495190     DOI: 10.1016/j.vetpar.2017.04.009

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  5 in total

1.  Toxoplasma gondii infection in pet cats and their owners in northeastern China:an important public health concern.

Authors:  Xin-Tong Li; Lu Wang; Yuan Ding; Wu-Wen Sun
Journal:  BMC Vet Res       Date:  2022-01-03       Impact factor: 2.741

Review 2.  Toxoplasma gondii Infections in Animals and Humans in Southern Africa: A Systematic Review and Meta-Analysis.

Authors:  Adejumoke O Omonijo; Chester Kalinda; Samson Mukaratirwa
Journal:  Pathogens       Date:  2022-01-28

Review 3.  Leishmania infection in cats and feline leishmaniosis: An updated review with a proposal of a diagnosis algorithm and prevention guidelines.

Authors:  André Pereira; Carla Maia
Journal:  Curr Res Parasitol Vector Borne Dis       Date:  2021-06-02

4.  Molecular detection of Anaplasma bovis, Ehrlichia canis and Hepatozoon felis in cats from Luanda, Angola.

Authors:  Ana Cristina Oliveira; Maria Francisca Luz; Sara Granada; Hugo Vilhena; Yaarit Nachum-Biala; Ana Patrícia Lopes; Luís Cardoso; Gad Baneth
Journal:  Parasit Vectors       Date:  2018-03-20       Impact factor: 3.876

5.  Prevalence of Toxoplasma gondii Measured by Western Blot, ELISA and DNA Analysis, by PCR, in Cats of Western Mexico.

Authors:  María de la Luz Galván-Ramírez; Claudia Charles-Niño; César Pedroza-Roldán; Carolina Salazar-Reveles; Karen Lissete Ocampo-Figueroa; Laura Roció Rodríguez-Pérez; Varinia Margarita Paez-Magallán
Journal:  Pathogens       Date:  2022-01-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.